Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857137 · ClinicalTrials.gov registry record · NA
Psychosis TMS Study
A NA study of Psychosis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05857137: Active NA study of Psychosis, sponsored by Massachusetts General Hospital.
NCT05857137 is a NA study of Psychosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05857137, a NA study of Psychosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields applied over the surface of the scalp.
Primary Outcome
Accuracy at high memory loads during performance of the Sternberg Item Recognition Paradigm will be assessed before and after the TMS interventions.
Conditions Studied
Interventions
- DEVICE Active TMS
- DEVICE Placebo TMS
Study Locations (1)
Massachusetts
- Martinos Center for Biomedical Imaging - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT05857137 still lists
NCT05857137 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Active TMS is the first listed.
NCT05857137 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05857137 about?
NCT05857137 is a clinical study titled "Psychosis TMS Study". The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields a...
What is the current status of trial NCT05857137?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-04. Estimated completion is 2026-07-30.
What conditions does trial NCT05857137 study?
This clinical trial studies the following conditions: Psychosis.
What interventions are being tested in trial NCT05857137?
The interventions under investigation include: Active TMS (DEVICE), Placebo TMS (DEVICE).
Who is sponsoring clinical trial NCT05857137?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05857137 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05857137's enrollment target sits among peer trials
20 32nd of 35 higher than 3 of 35 other Psychosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Determining the Role of Social Reward Learning in Social Anhedonia
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
RECRUITING · NA
-
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI